([content-module:CompanyOverview, NASDAQ:VKTX) Viking Therapeutics Inc. (NASDAQ:VKTX) reported earnings after the market closed on Apr. 23. The stock is pushing higher as investors attempt to sort ...

Shares of Viking Therapeutics (NASDAQ: VKTX), a clinical-stage drugmaker working on metabolic treatments, have tripled in value this year. Despite the huge run-up, analysts who follow the company ...

Viking Therapeutics (NASDAQ: VKTX) has captured the attention of investors, with its stock price skyrocketing over 400% in one year. This remarkable performance stems from the company's promising ...

2024 when Raymond James raised their price target to $116. Raymond James previously had an outperform for Viking Therapeutics Inc. Analysts arrive at stock ratings after doing extensive research ...

Learn More » Is Viking Therapeutics stock a bargain at its beaten-down price? Let's weigh some reasons to buy right now against the risks it faces to find out. Reasons to buy Viking Therapeutics ...

Following the release of its earnings report, Viking Therapeutics' stock price experienced a surge, climbing as much as 0%. This positive market response leaves some investors questioning if ...

On Tuesday, Oppenheimer analysts adjusted their outlook on Viking Therapeutics (NASDAQ: VKTX), reducing the stock’s price target from $164.00 to $100.00, while maintaining an Outperform rating ...

Some of VK2735's success could already be baked into the company's stock price, which makes the possibility of anything going wrong even riskier. So, whether Viking Therapeutics is for you ...

Viking Therapeutics sports a $7.2 billion market cap at recent prices, but commercial-stage biotech stocks tend to trade at mid-single-digit multiples of annual sales. That means its stock price ...

On Tuesday, Oppenheimer analysts adjusted their outlook on Viking Therapeutics (NASDAQ: VKTX), reducing the stock’s price target from $164.00 to $100.00, while maintaining an Outperform rating.The ...